In vitro study shows three-phase cement enhances DPSC proliferation and osteogenic differentiation, indicating bioactivity.
OBJECTIVE: S) on dental pulp stem cells (DPSCs) in vitro. METHODS: S were synthesized via sol-gel methods, combined with anhydrous calcium sulfate to produce a three-phase cement (3P cement), and characterized using scanning electron microscopy and X-ray diffraction. DPSCs were cultured on three dilutions of 3P cement and compared with mineral trioxide aggregate (MTA), Biodentine (BDNT) cement, and a control medium. Cell viability and proliferation were assessed using the MTT assay, apoptosis was evaluated by Annexin V/PI staining, and osteogenic differentiation was analyzed through alkaline phosphatase (ALP) activity, calcium deposition, and Alizarin Red staining on Days 7 and 14. RESULTS: The 3P cement exhibited excellent biocompatibility, with the highest DPSC proliferation observed at the 1/5 dilution. Apoptosis rates were minimal and comparable to controls. DPSCs cultured on 3P cement demonstrated significant increases in ALP activity, calcium deposition, and mineralized nodule formation compared to the control (p < 0.05). The osteogenic response was comparable to, or in some measures superior to, MTA and BDNT cement. CONCLUSIONS: The three-phase Sr- and Si-doped tricalcium silicate cement supports DPSC viability and promotes osteogenic differentiation, indicating its potential as a bioactive bone substitute. Further preclinical and in vivo studies are warranted to validate its regenerative efficacy in clinical applications.
No takes yet. Share an insight, caveat, or question.
Nasrabadi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: